Public limited company · Liège · incorporated on 25/03/2021 · 9,4 ETP
| 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 627,2 k € | +137.6% | 264,0 k € | -17.4% | 319,5 k € | +54.4% | 207,0 k € | +113.0% | 97,2 k € | |
| EBITDA | -154,8 k € | +57.5% | -364,7 k € | -587.1% | -53,1 k € | -315.5% | -12,8 k € | +41.7% | -21,9 k € | |
| Operating profit | -196,5 k € | +51.1% | -402,2 k € | -475.7% | -69,9 k € | -169.1% | -26,0 k € | +4.4% | -27,1 k € | |
| Profit/loss | -152,3 k € | +57.6% | -358,9 k € | -1339.1% | -24,9 k € | -56.2% | -16,0 k € | +25.2% | -21,3 k € | |
| Equity | 1,8 M € | +5.6% | 1,7 M € | +14.1% | 1,5 M € | +67.2% | 878,9 k € | +34.3% | 654,3 k € | |
| Total assets | 4,6 M € | +3.1% | 4,4 M € | +86.3% | 2,4 M € | +86.2% | 1,3 M € | +48.3% | 861,6 k € | |
| Cash | 229,0 k € | -84.9% | 1,5 M € | +95.7% | 776,6 k € | +14.1% | 680,6 k € | +4.9% | 648,6 k € | |
| Debts | 2,8 M € | +1.5% | 2,8 M € | +203.8% | 906,6 k € | +180.0% | 323,8 k € | +56.3% | 207,2 k € | |
| Staff | 9,4 | 7,7 | 4,3 | — | — | |||||
Public limited company loss-making in the latest fiscal year. Cash position declining (-84.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
CM4Cure is a Public limited company incorporated in 2021. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Liège. It employs on average 9,4 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette